Lonsurf trifluridine/tipiracil: Phase III data

The double-blind, Asian Phase III TERRA trial in 406 mCRC patients who were refractory to or

Read the full 166 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE